Pangenomic Health Inc. (NARA.CN)
CAD 0.14
(0.0%)
CAD 0.14
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.21 Million CAD | 208.11% |
| 2022 | 719.25 Thousand CAD | 115.05% |
| 2021 | 334.45 Thousand CAD | 145.43% |
| 2020 | 136.27 Thousand CAD | 4201.55% |
| 2019 | 3168.00 CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.54 Million CAD | -35.97% |
| 2024 Q1 | 2.4 Million CAD | 8.61% |
| 2023 Q1 | 1.01 Million CAD | 40.52% |
| 2023 FY | 2.21 Million CAD | 208.11% |
| 2023 Q4 | 2.21 Million CAD | 10.91% |
| 2023 Q3 | 1.99 Million CAD | 20.13% |
| 2023 Q2 | 1.66 Million CAD | 64.57% |
| 2022 Q1 | 379.27 Thousand CAD | 13.4% |
| 2022 FY | 719.25 Thousand CAD | 115.05% |
| 2022 Q4 | 719.25 Thousand CAD | 127.4% |
| 2022 Q3 | 316.28 Thousand CAD | -37.95% |
| 2022 Q2 | 509.75 Thousand CAD | 34.4% |
| 2021 Q3 | 990.1 Thousand CAD | 0.0% |
| 2021 Q1 | - CAD | -100.0% |
| 2021 Q4 | 334.45 Thousand CAD | -66.22% |
| 2021 FY | 334.45 Thousand CAD | 145.43% |
| 2020 FY | 136.27 Thousand CAD | 4201.55% |
| 2020 Q4 | 136.27 Thousand CAD | 0.0% |
| 2019 FY | 3168.00 CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AI/ML Innovations Inc. | 1.53 Million CAD | -43.934% |
| Diagnamed Holdings Corp. | 426.38 Thousand CAD | -419.743% |
| nDatalyze Corp. | 38.26 Thousand CAD | -5692.164% |
| Treatment.Com International Inc. | 1.47 Million CAD | -50.003% |
| Unidoc Health Corp. | 2.38 Million CAD | 6.904% |